The body’s tissues can get injured in many ways, but while some injuries heal perfectly, others don’t heal at all. A cut in the skin, for example, usually heals all on its own, while internal organs, such as the heart after a heart attack or the kidney after an acute injury, remain damaged, leading to diminished function. Most tissues of the body repair themselves using the same processes, but until now, drugs that target these pathways to enhance tissue repair in slow-healing organs have not been identified. That’s about to change.
FDA clears heart tissue regeneration drug AD-NP1 for clinical trials
